 MARIETTA, Ga., March 02, 2021 GLOBE NEWSWIRE -- MiMedx Group, Inc. Nasdaq: MDXG MiMedx or the Company, an industry leader in advanced wound care and a therapeutic biologics company, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2020 after the market close on Monday, March 8, 2021. MiMedx management will host a webcast and conference call to review its results on Tuesday, March 9, 2021, beginning at 9:30 am, Eastern Time. Participating on the call will be Timothy R. Wright, Chief Executive Officer, Peter M. Carlson, Chief Financial Officer, and Robert B. Stein, M.D., Ph.D., Executive Vice President, Research and Development. 